share_log

Hearing EF Hutton Initiates Coverage On Bone Biologics With Buy Rating And $2.25 Price Target

Benzinga ·  May 31, 2023 16:52
Hearing EF Hutton Initiates Coverage On Bone Biologics With Buy Rating And $2.25 Price Target
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment